Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Riminton

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Internal Medicine Journal|July 2, 2004
Primary immunodeficiency diseases in adulthoodD S Riminton, S Limaye
Current Directions in Autoimmunity|January 17, 2002
Novel concepts of tumor necrosis factor action in autoimmune pathologyD S Riminton, J D Sedgwick
Internal Medicine Journal|May 17, 2007
How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitalsM W Lin, P E Kirkpatrick, D S Riminton
The New Zealand Medical Journal|October 12, 1988
Cadaver kidney retrieval for transplantation in Canterbury and Westland: 1972-1987J A Roake, D S Riminton, J B Morton
Immunology Today|February 26, 2000
Tumor necrosis factor: a master-regulator of leukocyte movementJ D Sedgwick, D S Riminton, J G Cyster, et al.
Neurology|June 1, 1993
Inclusion body myositis presenting solely as dysphagiaD S Riminton, S T Chambers, P J Parkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxinH Hayder, R V Blanden, H Körner, et al.
The Journal of Experimental Medicine|November 14, 1997
Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targetingH Körner, D S Riminton, D H Strickland, et al.
Developmental Immunology|April 11, 2001
Increased thymic B cells but maintenance of thymic structure, T cell differentiation and negative selection in lymphotoxin-alpha and TNF gene-targeted miceA P Grech, D S Riminton, M J Gabor, et al.
Clinical and Experimental Immunology|August 12, 2009
Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiencyD A Fulcher, D T Avery, N L Fewings, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Internal Medicine Journal|July 2, 2004
Primary immunodeficiency diseases in adulthoodD S Riminton, S Limaye
Current Directions in Autoimmunity|January 17, 2002
Novel concepts of tumor necrosis factor action in autoimmune pathologyD S Riminton, J D Sedgwick
Internal Medicine Journal|May 17, 2007
How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitalsM W Lin, P E Kirkpatrick, D S Riminton
The New Zealand Medical Journal|October 12, 1988
Cadaver kidney retrieval for transplantation in Canterbury and Westland: 1972-1987J A Roake, D S Riminton, J B Morton
Immunology Today|February 26, 2000
Tumor necrosis factor: a master-regulator of leukocyte movementJ D Sedgwick, D S Riminton, J G Cyster, et al.
Neurology|June 1, 1993
Inclusion body myositis presenting solely as dysphagiaD S Riminton, S T Chambers, P J Parkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxinH Hayder, R V Blanden, H Körner, et al.
The Journal of Experimental Medicine|November 14, 1997
Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targetingH Körner, D S Riminton, D H Strickland, et al.
Developmental Immunology|April 11, 2001
Increased thymic B cells but maintenance of thymic structure, T cell differentiation and negative selection in lymphotoxin-alpha and TNF gene-targeted miceA P Grech, D S Riminton, M J Gabor, et al.
Clinical and Experimental Immunology|August 12, 2009
Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiencyD A Fulcher, D T Avery, N L Fewings, et al.
Pageof 2